71
Participants
Start Date
March 31, 2014
Primary Completion Date
May 1, 2021
Study Completion Date
May 1, 2021
Orteronel
Center for Cancer and Blood Disorders, Bethesda
Northeast Georgia Medical Center, Gainesville
Tennessee Oncology PLLC, Nashville
Tennessee Oncology PLLC, Chattanooga
Baptist Hospital East, Louisville
Hope Cancer Center, Terre Haute
Cancer Research Consortium of West Michigan, Grand Rapids
Cancer Centers of SW Oklahoma, Lawton
Center for Cancer and Blood Disorders, Fort Worth
Yale School of Medicine, New Haven
Collaborators (1)
Millennium Pharmaceuticals, Inc.
INDUSTRY
SCRI Development Innovations, LLC
OTHER